Drugs and Medical Treatments: Brexit

(asked on 19th October 2020) - View Source

Question to the Cabinet Office:

To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, pursuant to his oral contribution of 19 October 2020, Official Report, whether cross-border supply chains of medicines for the care and treatment of patients will continue without disruption after the transition period.


Answered by
Penny Mordaunt Portrait
Penny Mordaunt
Lord President of the Council and Leader of the House of Commons
This question was answered on 22nd October 2020

The Government, pharmaceutical industry and NHS work closely together to help ensure patients have access to the medicines and treatments they need.

The Department for Health and Social Care is working with trade bodies, product suppliers, and the health and care system to ensure continued supply of medicines and medical products at the end of the transition period. The Government has also written to medical suppliers about what steps they need to take.

Reticulating Splines